Loading...
Feasibility of Pharmacometabolomics to Identify Potential Predictors of Paclitaxel Pharmacokinetic Variability
PURPOSE: Paclitaxel is a commonly used chemotherapy drug with substantial variability in pharmacokinetics (PK) that affects treatment efficacy and toxicity. Pharmacometabolomic signatures that explain PK variability could be used to individualize dosing to improve therapeutic outcomes. The objective...
Na minha lista:
| Udgivet i: | Cancer Chemother Pharmacol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8319133/ https://ncbi.nlm.nih.gov/pubmed/34089352 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-021-04300-7 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|